Total Payments
$1,116
2024 Payments
$255.48
Companies
22
Transactions
58
Medicare Patients
3,542
Medicare Billing
$612,013
Payment Breakdown by Category
Food & Beverage$1,077 (96.5%)
Education$39.47 (3.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,077 | 54 | 96.5% |
| Education | $39.47 | 4 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $317.53 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $172.83 | 11 | $0 (2024) |
| Novo Nordisk Inc | $81.18 | 5 | $0 (2024) |
| Lilly USA, LLC | $80.94 | 5 | $0 (2023) |
| Amgen Inc. | $63.55 | 4 | $0 (2024) |
| Allergan, Inc. | $55.20 | 4 | $0 (2020) |
| PFIZER INC. | $50.18 | 3 | $0 (2024) |
| Ardelyx, Inc. | $41.68 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $36.56 | 2 | $0 (2024) |
| ABBVIE INC. | $31.14 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $255.48 | 15 | GlaxoSmithKline, LLC. ($48.89) |
| 2023 | $456.76 | 22 | AstraZeneca Pharmaceuticals LP ($139.29) |
| 2022 | $50.69 | 3 | GlaxoSmithKline, LLC. ($27.17) |
| 2021 | $26.44 | 2 | Genentech USA, Inc. ($13.58) |
| 2020 | $37.98 | 3 | AstraZeneca Pharmaceuticals LP ($23.12) |
| 2019 | $137.23 | 3 | AstraZeneca Pharmaceuticals LP ($123.19) |
| 2018 | $47.70 | 4 | Allergan Inc. ($26.30) |
| 2017 | $103.82 | 6 | Lilly USA, LLC ($51.66) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: PAIN | ||||||
| 08/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardio-renal | ||||||
| 06/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: DIABETES | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Inflammation | ||||||
| 03/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: RESPIRATORY | ||||||
| 02/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: RESPIRATORY | ||||||
| 02/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Diabetes | ||||||
| 11/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Cardio-renal | ||||||
| 10/06/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 09/22/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 941 | 1,932 | $291,645 | $143,868 |
| 2022 | 15 | 827 | 2,291 | $336,165 | $155,019 |
| 2021 | 17 | 817 | 2,184 | $321,495 | $164,259 |
| 2020 | 20 | 957 | 2,377 | $346,770 | $148,867 |
Total Patients
3,542
Total Services
8,784
Medicare Billing
$612,013
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 301 | 1,150 | $172,500 | $79,811 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 153 | 153 | $30,600 | $21,757 | 71.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 117 | 169 | $28,730 | $12,470 | 43.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 47 | 57 | $17,100 | $8,910 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 55 | $11,000 | $5,759 | 52.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $4,800 | $2,887 | 60.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $4,200 | $2,534 | 60.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 24 | 28 | $2,800 | $1,869 | 66.7% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 12 | 18 | $4,500 | $1,629 | 36.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $1,550 | $1,053 | 67.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 15 | 15 | $1,875 | $964.95 | 51.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 23 | 24 | $2,400 | $830.88 | 34.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 16 | 18 | $1,800 | $729.90 | 40.6% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 31 | 31 | $1,550 | $634.26 | 40.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 13 | $1,300 | $602.16 | 46.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 32 | $1,600 | $519.04 | 32.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 38 | $1,710 | $377.98 | 22.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 23 | $690.00 | $270.06 | 39.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 15 | 15 | $300.00 | $229.34 | 76.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 32 | $640.00 | $29.78 | 4.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 324 | 1,576 | $236,400 | $101,491 | 42.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 157 | 157 | $31,400 | $22,951 | 73.1% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 44 | 52 | $15,600 | $7,371 | 47.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 24 | 140 | $17,500 | $6,496 | 37.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 21 | 21 | $6,300 | $3,908 | 62.0% |
About Dr. Emad Jacob, MD
Dr. Emad Jacob, MD is a Internal Medicine healthcare provider based in Kearney, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1669622015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emad Jacob, MD has received a total of $1,116 in payments from pharmaceutical and medical device companies, with $255.48 received in 2024. These payments were reported across 58 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,077).
As a Medicare-enrolled provider, Jacob has provided services to 3,542 Medicare beneficiaries, totaling 8,784 services with total Medicare billing of $612,013. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Kearney, NJ
- Active Since 09/23/2008
- Last Updated 03/02/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669622015
Products in Payments
- FARXIGA (Drug) $155.12
- TRELEGY ELLIPTA (Drug) $150.11
- LOKELMA (Drug) $139.29
- AVYCAZ (Drug) $55.20
- Rybelsus (Drug) $46.67
- IBSRELA (Drug) $41.68
- Kerendia (Drug) $36.56
- Ozempic (Drug) $34.51
- TRULICITY (Drug) $33.96
- UBRELVY (Drug) $31.14
- JARDIANCE (Drug) $30.70
- NURTEC ODT (Drug) $30.36
- FREESTYLE LIBRE 2 (Device) $23.52
- BREZTRI AEROSPHERE (Drug) $23.12
- ANORO (Drug) $22.72
- Cologuard Collection Kit (Device) $20.55
- ELIQUIS (Drug) $19.82
- Prolia (Biological) $17.70
- TRADJENTA (Drug) $17.70
- VERQUVO (Drug) $17.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kearney
Dr. James Hall, M.d, M.D
Internal Medicine — Payments: $33,091
Internal Medicine $33,091
Dr. Michael Talalaev, D.o, D.O
Internal Medicine — Payments: $6,457
Internal Medicine $6,457
Scott Smith, M.d, M.D
Internal Medicine — Payments: $2,399
Internal Medicine $2,399
Dr. Adam Haussler, M.d, M.D
Internal Medicine — Payments: $1,706
Internal Medicine $1,706
Ishrat Saif, M.d, M.D
Internal Medicine — Payments: $1,525
Internal Medicine $1,525
Dr. Anirban Ghosh, Md, MD
Internal Medicine — Payments: $865.77
Internal Medicine $865.77